1477 Share Price Performance
HK$8.74
1.79 (25.76%)
Price HK$8.74
Share PriceHK$8.74
Why We're Not Concerned Yet About Ocumension Therapeutics' (HKG:1477) 26% Share Price Plunge
Sep 18
Ocumension Therapeutics Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
1477 Community Narratives
There are no narratives available yet.
Recent 1477 News & Updates
Earnings Update: Here's Why Analysts Just Lifted Their Ocumension Therapeutics (HKG:1477) Price Target To HK$9.27
Aug 25It's Unlikely That Ocumension Therapeutics' (HKG:1477) CEO Will See A Huge Pay Rise This Year
Jun 12Why Investors Shouldn't Be Surprised By Ocumension Therapeutics' (HKG:1477) 30% Share Price Surge
May 27Ocumension Therapeutics Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.31
- Gross Margin
- 42.58%
- Net Profit Margin
- -45.84%
- Debt/Equity Ratio
- 1.3%
Ocumension Therapeutics Competitors
Snowflake Analysis
About 1477
- Founded
- 2017
- Employees
- 505
- CEO
- WebsiteView website
Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. It discovers, develops, and commercializes therapies for ophthalmic patients. Its portfolio includes products and drugs for the treatment of chronic non-infectious uveitis, infective and allergic conjunctivitis, diabetic macular edema, dry eye, glaucoma and ocular hypertension, postoperative inflammation, choroidal neovascularization, bacterial conjunctivitis, retinitis pigmentosa, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. The company was founded in 2017 and is based in Suzhou, the People's Republic of China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 0.5%
- 3 Months: 17.0%
- 1 Year: 24.1%
- Year to Date: 26.2%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. Meanwhile, the market is actually up 24% over the past year. Earnings are forecast to grow by 27% annually. Market details ›